Kathryn Estopinal
Acute Care · Nashville, TNNPI 1194275560
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 52 manufacturers reported payments, led by Johnson & Johnson at 45.1% of the total. 2025 is the largest year on record at $20,359, more than ten times the $106 reported in 2021. Among acute care clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $97.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$11K
- Merck$8K
- AstraZeneca$792
- Regeneron Healthcare Solutions, Inc.$539
- Gilead$516
- Janssen Scientific Affairs, LLC$426
- plus $4K from 46 others
What the payments were for
- Speaking & faculty fees$14,13056%
- Travel & lodging$3,41013%
- Food & beverage$7,80531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,345 in reported general payments places this provider in the 95th percentile of 738 acute care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NubeqaDarolutamide | 23 | $315,260 |
| EliquisApixaban | 14 | $9,267 |
| Olanzapine | 38 | $807 |
| Ondansetron OdtOndansetron | 18 | $716 |
| Oxycodone Hcl | 36 | $537 |
| Levothyroxine Sodium | 37 | $219 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $202 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $134 |
| Prednisone | 23 | $106 |
| Amlodipine Besylate | 13 | $99 |
| Ciprofloxacin Hcl | 14 | $73 |
| Potassium Chloride | 11 | $52 |
| Furosemide | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerNubeqa | $126 | $315,26023 claims |
| PfizerEliquis | $203 | $9,26714 claims |
| Lilly USA, LLCOlanzapine | $26 | $80738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 738 acute care providers in Tennessee.
Other acute care in Nashville
- Haley HoyNashville$368K
- Shannon GraceNashville$57K
- Kelsey MartinNashville$42K
- Barbara BrownNashville$36K
- Elizabeth DavidsonNashville$33K
- Tisha BarzykNashville$23K
- Krista Kuhnert-GainerNashville$17K
- Donna SmithNashville$13K
- Amy CoxNashville$12K
- Emily SkotteNashville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.